CRL250117P145000
- 0.20
- 0.000.00%
Charles River Newsroom
William Blair Initiates Charles River(CRL.US) With Hold Rating
TD Cowen Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $182
TD Cowen Adjusts Charles River Laboratories International Price Target to $182 From $227
Charles River Labs Cut to Neutral From Buy by UBS
Charles River Analyst Ratings
UBS Downgrades Charles River(CRL.US) to Hold Rating, Cuts Target Price to $185
Mizuho Securities Maintains Charles River(CRL.US) With Hold Rating
Evercore Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $195
Evercore ISI Sticks to Their Hold Rating for Charles River Labs (CRL)
Jefferies Adjusts Price Target on Charles River Laboratories International to $169 From $196, Keeps Hold Rating
TD Cowen Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $227
BofA Securities Downgrades Charles River(CRL.US) to Hold Rating, Cuts Target Price to $210
Citi Maintains Charles River(CRL.US) With Sell Rating, Announces Target Price $175
Charles River Analyst Ratings
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $220
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $220
Cautious Hold Rating for Charles River Labs Amid Stable Projections and Slight Price Target Adjustment
Charles River Labs Is Maintained at Neutral by B of A Securities
Charles River Analyst Ratings
BofA Securities Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $210